Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Ehlers-Danlos Syndromes (EDS) Panel PreventionGenetics, part of Exact Sciences United States | 99 | 65 |
|
Low Bone Mass Panel (MitomeNGS) Baylor Genetics United States | 39 | 22 |
|
COL3A1 Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
COL3A1 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 2 | 1 |
|
COL3A1 Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 42 | 16 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Ehlers-Danlos syndrome, type III Bioarray Spain | 1 | 1 |
|
Ehlers-Danlos syndrome, type III Bioarray Spain | 1 | 1 |
|
Ehlers-Danlos syndrome, type III Bioarray Spain | 1 | 1 |
|
Ehlers-Danlos syndrome, type III Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 38 | 44 |
|
CeGaT GmbH Germany | 38 | 44 |
|
Fulgent Genetics United States | 2 | 1 |
|
Ehlers-Danlos Syndrome NGS Panel Fulgent Genetics United States | 97 | 21 |
|
Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Cardiovascular disorders panel Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 29 | 17 |
|
Fulgent Genetics United States | 187 | 60 |
|
Baylor Genetics United States | 842 | 637 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.